Figure 3
Risk of adverse outcomes of adherent NOAC use (PDC ≥80%) compared with non-adherent use (PDC <80%). CI, confidence interval; HR, hazard ratio; NOAC, non-vitamin K antagonist oral anticoagulant; PDC, proportion of days covered.
Risk of adverse outcomes of adherent NOAC use (PDC ≥80%) compared with non-adherent use (PDC <80%). CI, confidence interval; HR, hazard ratio; NOAC, non-vitamin K antagonist oral anticoagulant; PDC, proportion of days covered.
